Theravance Biopharma and Mylan settle a patent dispute with Eugia Pharma over Yupelri, delaying generic entry until 2039
https://seekingalpha.com/news/4456186-theravance-and-mylan-settle-patent-dispute-with-eugia-pharma
Theravance Biopharma and Mylan settle a patent dispute with Eugia Pharma over Yupelri, delaying generic entry until 2039
https://seekingalpha.com/news/4456186-theravance-and-mylan-settle-patent-dispute-with-eugia-pharma
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.